Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Reliance operationalises clean energy giga complex; elevates national exchequer contribution to Rs 2,16,472 crore in FY26
Reliance Industries has launched its clean energy operations. The company commissioned solar module manufacturing and began advanced work on a battery storage giga-factory. Reliance also significantly increased its contributions to the national exchequer. Jio Platforms accelerated its research and development, filing numerous new patents. The company is focused on enabling India's energy and digital future.
True North buys 25% stake in pharma co Embio
Private equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients for regulated markets. This investment will support Embio's research and development and capacity expansion. It will also help scale their contract development and manufacturing business. Embio specializes in complex APIs and synthetic biology.
Sensex falls 70 points, Nifty below 23,900 as US-Iran tensions simmer
Indian stock markets opened lower on Wednesday. Sensex and Nifty saw minor declines. Investors are watching US strikes on Iran and their effect on peace deal hopes. Broader markets are performing better. India VIX, a volatility measure, dropped. Top Sensex losers included HDFC Bank and Infosys. Sun Pharma shares led gains. Midcap and smallcap indices saw small gains.
Stocks to Watch today: Coal India, PhysicsWallah, ONGC, Siemens, IRCTC
Stocks to Watch today, May 27, 2026: MobiKwik, Sun Pharma, J&K Tyre, and Elgi Equipments are among some of the top stocks to remain in focus during today's trading session
Indices trade near flat line in early trade; breadth strong
Media, metal and PSU Bank shares advanced while consumer durables, FMCG and pharma shares declined.
Sun Pharma shares slip post Q4; analysts cautious on near-term upside
In the March quarter, Sun Pharma reported net profit at ₹2,714 crore, as compared to ₹2,150 crore a year ago, up 26.2 per cent year-on-year (Y-o-Y)
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.
Sun Pharma Q4 PAT jumps 26% YoY to Rs 2,714 cr
Sun Pharmaceutical Industries has reported 26.24% rise in consolidated net profit to Rs 2,714.03 crore in Q4 FY26 as against Rs 2,149.88 crore posted in the same period year ago.
Sun Pharma Q4 Results: Profit Jumps 26% Even As Margins Slip; Dividend Declared
Sun Pharma registered exceptional gains worth approximately Rs 1,700 crore in fiscal 2026.
Q4 Results Live Updates: Sun Pharma Revenue Up 12%; IRCON Profit Falls 10%
Key companies in focus include Sun Pharma, NTPC Green Energy, Hindalco Industries, Eicher Motors, Colgate-Palmolive (India), Fortis Healthcare and 3M India.
Sensex today | Stock Market Live: Sensex drops day's gain, Nifty near 23,700; Max Health, Sun Pharma top losers - BusinessLine
Sensex today | Stock Market Live: Sensex drops day's gain, Nifty near 23,700; Max Health, Sun Pharma top losersBusinessLine
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividend
Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while revenue declined 6% from Rs 15,520 crore reported in the October-December quarter of FY26.